news semaglutide Use of linked to doubled risk of neovascular macular degeneration UT San Antonio study: As

Researchers in the 26-week, double-blind study found that 36% of the 36 patients taking semaglutide: Achieved target blood glucose levels of over 70% time spent in range of 70 to 180 mg/dl

All the participants also took part in therapy designed to help reduce drinking

The Wegovy pill is closer in effectiveness to Lillys orforglipron, which helped people lose about 10.5% of their body weight after 72 weeks in a late-stage trial

Maria Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinics Precision Medicine for Obesity program

Impact of the injectable weight-loss medications, glucagon-like peptide-1 receptor agonists, on reproductive health in non-polycystic ovary syndrome state

Cost comparison Cost remains a key consideration in choosing between these therapies